Rchr
J-GLOBAL ID:200901060546010490
Update date: Apr. 13, 2024
Tsunoda Shin-ichi
ツノダ シンイチ | Tsunoda Shin-ichi
Affiliation and department:
Job title:
Professor
Other affiliations (1):
-
国立研究開発法人医薬基盤・健康・栄養研究所
客員研究員
Research field (1):
Pharmaceuticals - health and biochemistry
Research theme for competitive and other funds (23):
- 2022 - 2025 2型TNF受容体を介する免疫制御機構の解明とがん免疫療法への応用
- 2021 - 2024 免疫難病治療の新規モダリティを目指したTNFR1シグナル選択的阻害薬の創製
- 2020 - 2023 浮遊粒子状物質によるインフラマソーム活性化におけるレドックス制御の仕組みの解明
- 2018 - 2021 Molecular design of immunocytokines for control of regulatory T cell function
- 2018 - 2021 Study of TNFR2-APP3 signaling pathway and and its immuno-suppressive function
- 2014 - 2019 Development of a new diagnostic method for heart failure in collaboration with drug engineers
- 2016 - 2018 A trimeric structural fusion of an antagonistic tumor necrosis factor-alpha mutant enhances molecular stability
- 2015 - 2016 Characterization of tumor-derived exosomes for drug delivery
- 2014 - 2015 Development of mutant IFN-alpha as a drug against the chemo-resistance of cancer stem cells
- 2012 - 2015 Drug target discovery for autoimmune diseases by using a technology creating functional mutant proteins
- 2012 - 2012 Proteomic analysis of tumor-derived nanovesicles and its application for innovative diagnostic method.
- 2011 - 2012 Search for metastasis-related proteins in colorectal cancer by proteome analysis
- 2009 - 2012 The creation and safety assessment of cytokine adjuvant and nano-carrier for mucosal vaccine
- 2010 - 2011 Biomarker discovery in non-alcoholic steatohepatitis model mice
- 2008 - 2009 An organelle targeting system as a next generation technology for drug development
- 2008 - 2009 がん組織リンパ管を標的としたミサイル療法の開発
- 2006 - 2007 がんに対するTNF療法の最適化を目指した基盤技術の開発
- 2005 - 2006 癌の分子標的探索と治療最適化のためのゲノムプロファイリング
- 2005 - 2005 分子進化戦略を用いた安全かつ有効な抗腫瘍サイトカインの創製とそのDDS
- Drug Delivery System
- 分子イメージング
- 抗体エンジニアリング
- がん免疫療法
Show all
Papers (123):
-
Masaki Inoue, Kanako Yamashita, Yuta Tsuji, Midori Miki, Shota Amano, Taichi Okumura, Koki Kuge, Takao Tone, Shota Enomoto, Chinatsu Yoshimine, et al. Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander. The Journal of Immunology. 2021. 206. 8. 1740-1751
-
Higashisaka K, Nakashima A, Iwahara Y, Aoki A, Nakayama M, Yanagihara I, Lin Y, Nagano K, Tsunoda SI, Saito S, et al. Neutrophil Depletion Exacerbates Pregnancy Complications, Including Placental Damage, Induced by Silica Nanoparticles in Mice. Frontiers in immunology. 2018. 9. 1850
-
Takashi Nagano, Kazuya Nagano, Hiromi Nabeshi, Tokuyuki Yoshida, Haruhiko Kamada, Shin-ichi Tsunoda, Jian-Qing Gao, Kazuma Higashisaka, Yasuo Yoshioka, Yasuo Tsutsumi. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2017. 40. 5. 726-728
-
Masaki Inoue, Daisuke Ando, Haruhiko Kamada, Shintaro Taki, Mayumi Niiyama, Yohei Mukai, Takashi Tadokoro, Katsumi Maenaka, Taisuke Nakayama, Yuji Kado, et al. A trimeric structural fusion of an antagonistic tumor necrosis factor-alpha mutant enhances molecular stability and enables facile modification. JOURNAL OF BIOLOGICAL CHEMISTRY. 2017. 292. 16. 6438-6451
-
Takayuki Handa, Toshiro Hirai, Natsumi Izumi, Shun-ichi Eto, Shin-ichi Tsunoda, Kazuya Nagano, Kazuma Higashisaka, Yasuo Yoshioka, Yasuo Tsutsumi. Identifying a size-specific hazard of silica nanoparticles after intravenous administration and its relationship to the other hazards that have negative correlations with the particle size in mice. NANOTECHNOLOGY. 2017. 28. 13. 135101
more...
MISC (45):
-
T. Mori, K. Nagano, K. Higashisaka, Y. Yoshioka, H. Kamada, S. Tsunoda, Y. Tsutsumi. Optimization of an immune method to shorten time for inducing antibodies in mice. MOLECULAR BIOLOGY OF THE CELL. 2015. 26
-
Toshiro Hirai, Yasuo Yoshioka, Ko-ichi Ichihashi, Takahide Mori, Nobuo Nishijima, Takayuki Handa, Hideki Takahashi, Shin-ichi Tsunoda, Kazuma Higashisaka, Yasuo Tsutsumi. Silver nanoparticles induce silver nanoparticle-specific allergic responses. JOURNAL OF IMMUNOLOGY. 2014. 192
-
Yasuo Yoshioka, Asako Udaka, Toshiro Hirai, Hisae Aoshima, Ken Kokubo, Takumi Oshima, Tomoyuki Ohe, Tadahiko Mashino, Shin-ichi Tsunoda, Kazuma Higashisaka, et al. Fullerene C60 derivatives suppress the acquired immune responses. JOURNAL OF IMMUNOLOGY. 2014. 192
-
Kazuki Misato, Yasuo Yoshioka, Miyuki Uji, Asako Udaka, Takahide Mori, Manami Yamaguchi, Toshiro Hirai, Tokuyuki Yoshida, Hiromi Nabeshi, Tomoaki Yoshikawa, et al. The effects of oral administration of silica nanoparticles on immunologic response to the food antigen. JOURNAL OF IMMUNOLOGY. 2013. 190
-
Hideki Takahashi, Yasuo Yoshioka, Toshiro Hirai, Ko-ichi Ichihashi, Nobuo Nishijima, Tokuyuki Yoshida, Hiromi Nabeshi, Tomoaki Yoshikawa, Shin-ichi Tsunoda, Kazuma Higashisaka, et al. The size effects of amorphous silica nanoparticles on atopic dermatitis-like skin lesion. JOURNAL OF IMMUNOLOGY. 2013. 190
more...
Return to Previous Page